Search Results - "BARRIENTOS, MARGARITA"

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes by Barrientos‐Pérez, Margarita, Hsia, Daniel S., Sloan, Lance, Nell, Haylene, Mungur, Ounisha, Hovsepian, Lionel, Schmider, Wolfgang, Spranger, Robert, Yang, Na, Niemoeller, Elisabeth

“…Objective The aim of this study was to investigate the pharmacokinetic, pharmacodynamic and safety profile of the glucagon‐like peptide‐1 receptor agonist,…”
Get full text

Once-Weekly Semaglutide in Adolescents with Obesity by Weghuber, Daniel, Barrett, Timothy, Barrientos-Pérez, Margarita, Gies, Inge, Hesse, Dan, Jeppesen, Ole K., Kelly, Aaron S., Mastrandrea, Lucy D., Sørrig, Rasmus, Arslanian, Silva

“…In this trial, adolescents with obesity assigned to weekly subcutaneous semaglutide plus lifestyle intervention had a greater reduction in BMI than those who…”
Get full text

Latin American consensus: children born small for gestational age by Boguszewski, Margaret C S, Mericq, Veronica, Bergada, Ignacio, Damiani, Durval, Belgorosky, Alicia, Gunczler, Peter, Ortiz, Teresa, Llano, Mauricio, Domené, Horacio M, Calzada-León, Raúl, Blanco, Armando, Barrientos, Margarita, Procel, Patricio, Lanes, Roberto, Jaramillo, Orlando

“…Children born small for gestational age (SGA) experience higher rates of morbidity and mortality than those born appropriate for gestational age. In Latin…”
Get full text

Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes by Arslanian, Silva A., Hannon, Tamara, Zeitler, Philip, Chao, Lily C., Boucher-Berry, Claudia, Barrientos-Pérez, Margarita, Bismuth, Elise, Dib, Sergio, Cho, Jang Ik, Cox, David

“…This trial compared once-weekly dulaglutide, a GLP-1 receptor agonist, with placebo for glycemic control in youths with type 2 diabetes who may have been…”
Get full text

Liraglutide in Children and Adolescents with Type 2 Diabetes by Tamborlane, William V, Barrientos-Pérez, Margarita, Fainberg, Udi, Frimer-Larsen, Helle, Hafez, Mona, Hale, Paula M, Jalaludin, Muhammad Y, Kovarenko, Margarita, Libman, Ingrid, Lynch, Jane L, Rao, Paturi, Shehadeh, Naim, Turan, Serap, Weghuber, Daniel, Barrett, Timothy

“…This trial assessed the efficacy and safety of liraglutide as compared with placebo, added to metformin (with or without basal insulin treatment), in children…”
Get full text

Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises by Weghuber, Daniel, Barrientos-Pérez, Margarita, Kovarenko, Margarita

“…Youth-onset type 2 diabetes (T2D) is increasing in many countries, creating large personal and societal burdens. While many primary health-care professionals…”
Get more information

Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes by Jalaludin, Muhammad Yazid, Barrientos-Pérez, Margarita, Hafez, Mona, Lynch, Jane, Shehadeh, Naim, Turan, Serap, Weghuber, Daniel

“…Background The prevalence of type 2 diabetes is increasing in youths and differs from adult-onset type 2 diabetes in its characteristics and progression…”
Get full text

5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial by ARSLANIAN, SILVA A., CHO, JANG IK, HANNON, TAMARA S., ZEITLER, PHILIP, CHAO, LILY, BARRIENTOS, MARGARITA, BOUCHER-BERRY, CLAUDIA C., BISMUTH, ELISE, DIB, SERGIO A., COX, DAVID

“…AWARD-PEDS was a Phase 3 trial to assess the efficacy and safety of dulaglutide (DU) , a once-weekly GLP-1 receptor agonist, in youth (10 to <18 years old)…”
Get full text

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity by Kelly, Aaron S, Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva

“…Adolescents with obesity and a poor response to lifestyle therapy alone were randomly assigned to receive either liraglutide or placebo subcutaneously once…”
Get full text

Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial by Fox, Claudia K, Barrientos-Pérez, Margarita, Bomberg, Eric M, Dcruz, John, Gies, Inge, Harder-Lauridsen, Nina M, Jalaludin, Muhammad Yazid, Sahu, Kushal, Weimers, Petra, Zueger, Thomas, Arslanian, Silva

“…No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of…”
Get full text

Once-Weekly Subcutaneous Semaglutide 2.4 mg in Adolescents With Overweight or Obesity by Weghuber, Daniel, Barrett, Timothy, Barrientos-Perez, Margarita, Gies, Inge, Hesse, Dan, Jeppesen, Ole, Kelly, Aaron, Mastrandrea, Lucy, Sørrig, Rasmus, Arslanian, Silva

Get full text

Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes by Senoo, Yuki, Kami, Masahiro, Arslanian, Silva A., Cox, David

“…To the Editor: Arslanian et al. (Aug. 4 issue) 1 report that a once-weekly subcutaneous injection of dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor…”
Get full text

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial by Laffel, Lori M, Danne, Thomas, Klingensmith, Georgeanna J, Tamborlane, William V, Willi, Steven, Zeitler, Philip, Neubacher, Dietmar, Marquard, Jan, Bardymova, Tatiana, Barrientos Perez, Margarita, Bethin, Kathleen, Bjornstad, Petter, Bondar, Irina, Chen, Mimi, Choi, Jin-Ho, Clements, Mark A, Colomar, Javier Ricardo, Daniels, Mark, Deerochanawong, Chaicharn, Desai, Vivek S, Desmangles, Jean-Claude G, Dillon, Robert G, Dixit, Naznin M, Du, Hongwei, Edelen, Rachel, Espinoza Peralta, Diego, Felipe Gacioppo, María Verónica, Ferraz, Tania Maria Bulcão Lousada, Galkina, Galina, Gallagher, Mary Patricia, George, Minu, Gonzalez, Edgar, Gottschalk, Michael Everett, Guido, Giancarlo, Hassan, Amir Ali, Hershkovitz, Eli, Huerta-Saenz, Lina P, Hwang, Jin Soon, Ibarra Gomez, Jaime Orlando, Irizarry Gonzalez, Lydia, Jain, Nina, Jelley, David H, Kim, Ho-Seong, Kovalenko, Tatiana, Laffel, Lori Michelle B, Leichter, Steven B, Liberatore Jr, Raphael Del Roio, Lynch, Jane, Mahmud, Farid Hussain, Malievskiy, Oleg Arturovich, Muir, Andrew, Nelson, Bryce A, Nevarez Ruiz, Luis Alejandro, Olson, Micah L, Pelayo Orozco, Emilia Susana, Peterkova, Valentina, Ramírez Mendoza, Fernando Ramón, Reddy, Konda Mohan, Rodriguez, Henry, Saenz, Javier Andres, Samoilova, Julia, Schwab, Karl-Otfried, Shah, Sejal H, Shehadeh, Naim, Shoemaker, Ashley H, Skorodok, Yulia, Sobolev, Aleksandr, Solís, Silvana Ernestina, Srinivasan, Shylaja, Tamborlane, William V, Tsalikian, Eva, Valeeva, Farida, Vance, Carl D, Velasquez-Mieyer, Pedro A, Violante Ortiz, Rafael Margarito, Votyakova, Olga, Wei, Haiyan, Weinstock, Ruth S, Wheeler, Mark D, Wicklow, Brandy Alexandra, Willi, Steven M, Wintergerst, Kupper A, Wolf, Risa M, Wood, Jamie Ruth, Yaliwal, Chandan, Yupanqui Lozno, Hernán

“…The incidence of type 2 diabetes in young people is increasing, but treatments remain limited. We aimed to assess the efficacy and safety of an empagliflozin…”
Get full text

1329-P: National Differences and Similarities in Youth-Onset Type 2 Diabetes by LYNCH, JANE L., BARRIENTOS-PÉREZ, MARGARITA, HAFEZ, MONA, JALALUDIN, MUHAMMAD YAZID, KOVARENKO, MARGARITA, PATURI, VISHNUPRIYA RAO, WEGHUBER, DANIEL

“…Background: With the recent increased awareness of youth-onset type 2 diabetes (T2D) cases, an overview of national differences in epidemiology data is needed…”
Get full text

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2) by Wheeler, Mark D., Barrientos-Perez, Margarita, Lo, Fu-Sung, Liang, Bo, Lunsford, Alison, Thórisdóttir, Ólöf, Zuckerman-Levin, Nehama

“…There are limited studies evaluating the safety and efficacy of treatments in young people with type 2 diabetes (T2D). This study compared the efficacy and…”
Get full text

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial by Kelly, Aaron S, Auerbach, Pernille, Barrientos-Perez, Margarita, Gies, Inge, Hale, Paula M, Marcus, Claude, Mastrandrea, Lucy D, Prabhu, Nandana, Arslanian, Silva

“…Background: Pediatric obesity is a chronic disease with rising prevalence and limited treatment options; first-line intervention is lifestyle therapy, which is…”
Get full text

Mesa redonda sobre la responsabilidad del hombre frente a la creación by Augusto Uribe, Augusto Uribe, Enrique Posada, Augusto González, Margarita María Barrientos

“…En la reunión se abordaron los siguientes temas: - Comentarios a Gen. 1, 28 - Análisis lógico de la proposición de  Gen. 1, 28 - El mandato bíblico y la…”
Get full text

Hiperinsulinemia y resistencia insulínica en niños de dos escuelas públicas de Oaxaca, México by Rosas-Sumano, Ana Beatriz, Rodal-Canales, Francisco Javier, Barrientos Pérez, Margarita, Cárdenas-Morales, Beatriz Eugenia, Pérez-Campos Mayoral, Laura, Pérez-Campos, Eduardo

Get full text

Consenso Latinoamericano: Niños pequeños para la edad gestacional by Boguszewski, Margaret CS, Mericq, Verónica, Bergada, Ignacio, Damiani, Durval, Belgorosky, Alicia, Gunczler, Peter, Ortiz, Teresa, Llano, Mauricio, Domené, Horacio M, Calzada-León, Raúl, Blanco, Armando, Barrientos, Margarita, Procel, Patricio, Lanes, Roberto, Jaramillo, Orlando

Get full text

Hyperinsulinemia and insulin resistance in children by Rosas-Sumano, Ana Beatriz, Rodal-Canales, Francisco Javier, Barrientos Pérez, Margarita, Cárdenas-Morales, Beatriz Eugenia, Pérez-Campos Mayoral, Laura, Pérez-Campos, Eduardo

“…Obesity during childhood is a risk factor for developing cardiovascular diseases during adulthood. To measure insulin and glucose levels and parameters of…”
Get full text